Resources

PATH has developed a low-cost and straightforward approach for protecting aluminum-adjuvanted vaccines from irreversible damage that results from freezing. Many current vaccines of importance to global health contain an aluminum-salt adjuvant (such as aluminum hydroxide or aluminum phosphate) and could benefit from this freeze-protection technology. There is no intellectual property barrier for manufacturers wishing to adopt the technology; it has been placed in the public domain. This technical dossier summarizes the rationale for freeze protection, application of the technology to specific vaccines, the data obtained to date, and comments on the likely regulatory pathway for vaccines incorporating the technology.

Part of the Technology Updates series, this fact sheet describes PATH's work to develop and deploy OpenLMIS, a community-focused initiative to improve health commodity supply chains, including an open-source, electronic logistics management information system. Find out more about PATH's work in digital health solutions.

This fact sheet provides an overview of rotavirus disease and vaccines in Zimbabwe. It includes information about the tremendous burden of rotavirus diarrhea in Zimbabwean children, rotavirus diarrhea treatment and prevention strategies, and the effectiveness of rotavirus vaccines.

This fact sheet provides an overview of rotavirus disease and vaccines in Djibouti. It includes information about the tremendous burden of rotavirus diarrhea in Djiboutian children, rotavirus diarrhea treatment and prevention strategies, and the effectiveness of rotavirus vaccines.

This fact sheet describes PATH's activities to increase the coverage and timeliness of hepatitis B birth dose vaccination in Vietnam.